- Report
- May 2026
- 110 Pages
United States
From €4389EUR$4,750USD£3,676GBP
- Report
- May 2026
- 180 Pages
United States
From €4389EUR$4,750USD£3,676GBP
- Report
- May 2026
- 180 Pages
United States
From €4389EUR$4,750USD£3,676GBP
- Report
- May 2026
- 140 Pages
United States
From €4389EUR$4,750USD£3,676GBP
- Report
- April 2026
- 90 Pages
United States
From €4389EUR$4,750USD£3,676GBP
- Report
- October 2026
United States
From €3686EUR$3,990USD£3,088GBP
- Report
- October 2026
Middle East
From €3686EUR$3,990USD£3,088GBP
- Report
- October 2026
Asia Pacific
From €3686EUR$3,990USD£3,088GBP
- Report
- February 2026
- 108 Pages
Europe
From €5539EUR$5,995USD£4,639GBP
- Report
- February 2026
- 85 Pages
North America
From €5539EUR$5,995USD£4,639GBP
- Report
- May 2026
- 150 Pages
United States
From €4481EUR$4,850USD£3,753GBP
- Report
- March 2026
- 269 Pages
United States
From €4481EUR$4,850USD£3,753GBP
- Report
- May 2026
- 150 Pages
United States
From €4481EUR$4,850USD£3,753GBP
- Report
- April 2026
- 266 Pages
United States
From €4481EUR$4,850USD£3,753GBP
- Report
- March 2026
- 170 Pages
United States
From €4481EUR$4,850USD£3,753GBP
- Report
- March 2026
- 150 Pages
United States
From €4481EUR$4,850USD£3,753GBP
- Report
- March 2026
- 150 Pages
United States
From €4481EUR$4,850USD£3,753GBP
- Report
- March 2026
- 210 Pages
United States
From €4481EUR$4,850USD£3,753GBP
- Report
- March 2026
- 286 Pages
United States
From €4481EUR$4,850USD£3,753GBP
- Report
- March 2026
- 220 Pages
United States
From €4481EUR$4,850USD£3,753GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more